Edwards Lifesciences EW
NYSE EW
$103.61 +1.47 (+1.44%)
As of: Nov 9, 2026 · 9:55 AM EST

Edwards Lifesciences (EW) Gains from Sales and Divestitures (2024 - 2025)

Updated

Analysis

Edwards Lifesciences (EW) Gains from Sales and Divestitures (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 258.23 Bn 234.75 Bn 5.13 Bn
2 Abbott Laboratories 189.69 Bn 163.55 Bn 7.39 Bn
3 Danaher 161.73 Bn 141.39 Bn 3.84 Bn
4 Intuitive Surgical 159.20 Bn 139.49 Bn 2.08 Bn
5 Medtronic 130.49 Bn 95.74 Bn 6.34 Bn
6 Stryker 125.08 Bn 111.27 Bn 4.25 Bn
7 Boston Scientific 63.06 Bn 58.50 Bn 3.43 Bn
8 Edwards Lifesciences 59.30 Bn 42.51 Bn 1.35 Bn
9 Becton Dickinson 58.40 Bn 55.55 Bn 2.32 Bn
10 Agilent Technologies 49.44 Bn 42.33 Bn 1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 33.90 Mn
Dec 31, 2024 10.80 Mn
API Access

Edwards Lifesciences Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=EW&period=max&api_key=YOUR_API_KEY